Angiotensin-converting enzyme and progression of white matter lesions and brain atrophy - The SMART-MR study

Journal of Alzheimer's Disease

Volumn 29, Issue 1, 2012, Pages 39-49

  Jochemsen, Hadassa M ^a   Geerlings, Mirjam I ^a   Grool, Anne M ^a   Vincken, Koen L ^b   Mali, Willem P T M ^a   Van Der Graaf, Yolanda ^a   Muller, Majon ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Brain infarction; cohort studies; magnetic resonance imaging; neurodegenerative diseases; other cerebrovascular disorders; renin angiotensin system

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; BRAIN ATHEROSCLEROSIS; BRAIN ATROPHY; BRAIN DAMAGE; BRAIN SIZE; BRAIN VENTRICLE; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; WHITE MATTER; WHITE MATTER LESION;

EID: 84863418581     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-111772     Document Type: Article

References (36)

1. Launer LJ (2005) The epidemiologic study of dementia: A life-long quest? Neurobiol Aging 26, 335-340.
2. Breteler MM (2000) Vascular risk factors for Alzheimer's disease: An epidemiologic perspective. Neurobiol Aging 21, 153-160.
3. Kehoe PG, Wilcock GK (2007) Is inhibition of the reninangiotensin system a new treatment option for Alzheimer's disease? Lancet Neurol 6, 373-378. (Pubitemid 46389616)
4. Studdy PR, Lapworth R, Bird R (1983) Angiotensin-converting enzyme and its clinical significance - a review. J Clin Pathol 36, 938-947. (Pubitemid 13030613)
5. Dufouil C, Chalmers J, Coskun O, Besancon V, Bousser MG, Guillon P, MacMahon S, Mazoyer B, Neal B, Woodward M, Tzourio-Mazoyer N, Tzourio C (2005) Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 112, 1644-1650. (Pubitemid 41324527)
6. Ohrui T, Tomita N, Sato-Nakagawa T, Matsui T, Maruyama M, Niwa K, Arai H, Sasaki H (2004) Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression. Neurology 63, 1324-1325. (Pubitemid 39350046)
7. Iadecola C, Gorelick PB (2004) Hypertension, angiotensin, and stroke: Beyond blood pressure. Stroke 35, 348-350. (Pubitemid 38174402)
8. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342, 145-153.
9. Peters R, Beckett N, Forette F, Tuomilehto J, Clarke R, Ritchie C, Waldman A, Walton I, Poulter R, Ma S, Comsa M, Burch L, Fletcher A, Bulpitt C (2008) Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): A double-blind, placebo controlled trial. Lancet Neurol 7, 683-689.
10. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86, 1343-1346. (Pubitemid 20370444)
11. Paternoster L, Chen W, Sudlow CL (2009) Genetic determinants of white matter hyperintensities on brain scans: A systematic assessment of 19 candidate gene polymorphisms in 46 studies in 19,000 subjects. Stroke 40, 2020-2026.
12. Sharma P (1998) Meta-analysis of the ACE gene in ischaemic stroke. J Neurol Neurosurg Psychiatry 64, 227-230.
13. Hemming ML, Selkoe DJ (2005) Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. J Biol Chem 280, 37644-37650. (Pubitemid 41642372)
14. Hu J, Igarashi A, Kamata M, Nakagawa H (2001) Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem 276, 47863-47868.
15. Sleegers K, den HT, van Dijk EJ, Hofman A, Bertoli-Avella AM, Koudstaal PJ, Breteler MM, van Duijn CM (2005) ACE gene is associated with Alzheimer's disease and atrophy of hippocampus and amygdala. Neurobiol Aging 26, 1153-1159.
16. Belbin O, Brown K, Shi H, Medway C, Abraham R, Passmore P, Mann D, Smith AD, Holmes C, McGuinness B, Craig D, Warden D, Heun R, Kolsch H, Love S, Kalsheker N, Williams. J, Owen MJ, Carrasquillo M, Younkin S, Morgan K, Kehoe PG (2011) A multi-center study of ACE and the risk of late-onset Alzheimer's disease. J Alzheimers Dis 24, 587-597.
17. Muller M, Appelman AP, van der Graaf Y, Vincken KL, Mali WP, Geerlings MI (2011) Brain atrophy and cognition: Interaction with cerebrovascular pathology? Neurobiol Aging 32, 885-893.
18. Geerlings MI, Appelman AP, Vincken KL, Algra A, Witkamp TD, Mali WP, van der Graaf Y (2010) Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease. The SMART-MR study. Atherosclerosis 210, 130-136.
19. Anbeek P, Vincken KL, van Osch MJ, van der Grond J (2004) Probabilistic segmentation of white matter lesions in MR imaging. Neuroimage 21, 1037-1044. (Pubitemid 38314966)
20. Anbeek P, Vincken KL, van Bochove GS, Bisschops RH, van der Grond J (2005) Probabilistic segmentation of brain tissue in MR imaging. Neuroimage 27, 795-804. (Pubitemid 41317249)
21. Maes F, Collignon A, Vandermeulen D, Marchal G, Suetens P (1997) Multimodality image registration by maximization of mutual information. IEEE Trans Med Imaging 16, 187-198. (Pubitemid 127762930)
22. Smith SM (2002) Fast robust automated brain extraction.Hum Brain Mapp 17, 143-155.
23. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, DeCarli C, Merino JG, Kalaria RN, Vinters HV, Holtzman DM, Rosenberg GA, Wallin A, Dichgans M, Marler JR, Leblanc GG (2006) National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards. Stroke 37, 2220-2241. (Pubitemid 44337162)
24. Brand N, Jolles J (1985) Learning and retrieval rate of words presented auditorily and visually. J Gen Psychol 112, 201-210.
25. Rey A (1941) "L'examen psychologique dans les cas d'encephalopathie traumatique. (Les problems.)". Archives de Psychologie 28, 215-285.
26. Robertson IH, Wart T, Ridgeway V, Nimmo-Smith I (1994) The test of everyday attention. Bury St Edmonds, UK. Thames Vally Test Company.
27. Burgess PW, Shallice T (1996) Bizarre responses, rule detection and frontal lobe lesions. Cortex 32, 241-259. (Pubitemid 26193470)
28. Lezak MD (1995) Neuropsychological assessment. [3th ed]. Oxford, Oxford University Press.
29. Schmand B, Geerlings MI, Jonker C, Lindeboom J (1998) Reading ability as an estimator of premorbid intelligence: Does it remain stable in emergent dementia? J Clin Exp Neuropsychol 20, 42-51. (Pubitemid 28318057)
30. Beneteau B, Baudin B, Morgant G, Giboudeau J, Baumann FC (1986) Automated kinetic assay of angiotensin-converting enzyme in serum. Clin Chem 32, 884-886. (Pubitemid 17028376)
31. Donders AR, van der Heijden GJ, Stijnen T, Moons KG (2006) Review: A gentle introduction to imputation of missing values. J Clin Epidemiol 59, 1087-1091. (Pubitemid 44374314)
32. Rubin DB, Schenker N (1991) Multiple imputation in healthcare databases: An overview and some applications. Stat Med 10, 585-598.
33. Brenner D, Labreuche. J, Pico F, Scheltens P, Poirier O, Cambien F, Amarenco P (2008) The renin-angiotensin-aldosterone system in cerebral small vessel disease. J Neurol 255, 993-1000.
34. Skoog I (1998) A review on blood pressure and ischaemic white matter lesions. Dement Geriatr Cogn Disord 9 (Suppl 1), 13-19.
35. Kehoe PG, Miners S, Love S (2009) Angiotensins in Alzheimer's disease - friend or foe? Trends Neurosci 32, 619-628.
36. Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, Wolozin B (2010) Use of angiotensin receptor blockers and risk of dementia in a Predominantly male population: Prospective cohort analysis. BMJ 340, b5465.